Prediction model for synergistic anti-tumor multi-compound combinations from traditional Chinese medicine based on

Mengqiu Sun1, Shengnan She1, Hengwei Chen1

  • 1Department of Pharmaceutics, School of Pharmacy, Jiangsu University, Zhenjiang 212013, P. R. China.

Insights

Machine learning accurately predicts synergistic Traditional Chinese Medicine (TCM) compounds for cancer therapy. An XGBoost model identified potent combinations from Radix Paeoniae Rubra, validating their anti-tumor effects.

Area of Science:

  • Computational biology and bioinformatics
  • Pharmacology and natural product chemistry
  • Oncology and cancer therapeutics

Background:

  • Traditional Chinese Medicine (TCM) offers synergistic multi-compound, multi-target therapeutic potential for complex cancers.
  • Identifying key contributors and mechanisms in TCM synergistic anti-cancer effects remains a significant challenge.
  • Machine learning presents a novel computational approach to decipher complex TCM formulations.

Purpose of the Study:

  • To develop and validate a machine learning model for predicting synergistic anti-cancer compound combinations from TCM.
  • To identify specific synergistic combinations within Radix Paeoniae Rubra (RPR) with potential anti-tumor activity.
  • To evaluate the model's reliability and predictive accuracy using experimental validation.

Main Methods:

  • Construction of an extreme gradient boosting (XGBoost) prediction model.
  • Integration of diverse datasets including cancer cell line gene expression, natural compound targets, and drug response data.
  • Model evaluation using metrics such as Mean Square Error (MSE), Mean Absolute Error (MAE), and Root Mean Squared Error (RMSE) on a test dataset.

Main Results:

  • The optimal XGBoost model demonstrated robust performance with MSE=0.66, MAE=0.61, and RMSE=0.81.
  • Predicted synergistic anti-tumor combinations D15 (Paeonol-Ethyl gallate) and D13 (Paeoniflorin-Paeonol) from RPR were identified.
  • Experimental validation confirmed the anti-tumor efficacy of D15 and D13 on MCF-7 cells, with D13 showing significant contribution in RPR-Cortex Moutan compatibility.

Conclusions:

  • The developed XGBoost model is a reliable tool for efficiently predicting synergistic anti-tumor multi-compound combinations from TCM.
  • This approach facilitates the discovery of novel therapeutic strategies by elucidating the synergistic mechanisms of TCM.
  • The findings pave the way for integrating computational methods into TCM research for modern drug discovery.